PubRank

JAK-STAT (JAKSTAT)

Journal PubWeight™ 120.77‹?›

Top papers

Rank Title Year PubWeight™‹?›
51 LIF-STAT signaling and trophoblast biology. 2013 0.84
52 Wheezing and itching: The requirement for STAT proteins in allergic inflammation. 2012 0.84
53 STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. 2012 0.84
54 Oxidative metabolism in cancer: A STAT affair? 2013 0.84
55 JAK-STAT in heterochromatin and genome stability. 2013 0.83
56 The JAK-STAT pathway in hypertrophic stress signaling and genomic stress response. 2012 0.82
57 Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart. 2013 0.82
58 The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective. 2012 0.82
59 The spectrum of STAT functions in mammary gland development. 2012 0.82
60 Genomic and computational approaches to dissect the mechanisms of STAT3's universal and cell type-specific functions. 2013 0.82
61 JAK-STAT in lipid metabolism of adipocytes. 2013 0.82
62 High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway. 2012 0.82
63 Identification of STAT target genes in adipocytes. 2013 0.82
64 Diversification of dendritic cell subsets: Emerging roles for STAT proteins. 2013 0.81
65 JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation. 2012 0.81
66 Functions of the Drosophila JAK-STAT pathway: Lessons from stem cells. 2012 0.81
67 STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells. 2012 0.81
68 The oncogenic FIP1L1-PDGFRα fusion protein displays skewed signaling properties compared to its wild-type PDGFRα counterpart. 2015 0.81
69 Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy. 2013 0.81
70 The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom? 2013 0.81
71 STAT2 phosphorylation and signaling. 2013 0.81
72 Effects of JAK2-STAT3 signaling after cerebral insults. 2014 0.80
73 A new mechanism for growth hormone receptor activation of JAK2, and implications for related cytokine receptors. 2014 0.80
74 JAK-STAT signaling in cardiomyogenesis of cardiac stem cells. 2012 0.80
75 Propofol mediates signal transducer and activator of transcription 3 activation and crosstalk with phosphoinositide 3-kinase/AKT. 2014 0.80
76 Protein tyrosine phosphatases as wardens of STAT signaling. 2014 0.80
77 Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease. 2013 0.80
78 The Drosophila JAK-STAT pathway. 2013 0.80
79 Acetylation and sumoylation control STAT5 activation antagonistically. 2012 0.80
80 STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis. 2013 0.80
81 Engaged for survival: From cadherin ligation to STAT3 activation. 2013 0.80
82 STAT2 signaling and dengue virus infection. 2014 0.80
83 JAK-STAT and feeding. 2013 0.80
84 Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer. 2013 0.79
85 ROCKing the JAKs. 2013 0.79
86 Making milk: A new link between STAT5 and Akt1. 2013 0.79
87 STAT3 as a new autophagy regulator. 2013 0.79
88 IL-4, JAK-STAT signaling, and pain. 2014 0.79
89 JAK2-STAT5B pathway and osteoblast differentiation. 2013 0.79
90 A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells. 2012 0.79
91 Egr2 and Egr3 are the unique regulators for systemic autoimmunity. 2013 0.79
92 STATs and macrophage fusion. 2013 0.78
93 Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells. 2012 0.78
94 Roles of STATs signaling in cardiovascular diseases. 2012 0.78
95 Modulation of human JAK-STAT pathway signaling by functionally conserved regulators. 2012 0.78
96 JAK-STAT signaling and myocardial glucose metabolism. 2013 0.78
97 The cardioprotective effects of urocortin are mediated via activation of the Src tyrosine kinase-STAT3 pathway. 2013 0.78
98 CCL2 at the crossroad of cancer metastasis. 2013 0.78
99 Computational models of the JAK1/2-STAT1 signaling. 2013 0.78
100 The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies. 2013 0.77
Next 50